Exact Mass: 335.24362540000004
Exact Mass Matches: 335.24362540000004
Found 178 metabolites which its exact mass value is equals to given mass value 335.24362540000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ankorine
C19H29NO4 (335.20964740000005)
A pyridoisoquinoline that is 1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinoline which is substituted at positions 2, 3, and 8 by 2-hydroxyethyl, ethyl, and hydroxy groups, respectively, and by methoxy groups at positions 9 and 10 (the 2R,3R,11bS stereoisomer). It is a benzo[a]quinolizidine alkaloid isolated from the Indian medicinal plant Alangium lamarckii.
9-peroxy-5Z,7E,11Z,14Z-eicosatetraenoate
This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.
11-peroxy-5Z,8Z,12E,14Z-eicosatetraenoate
This compound belongs to the family of Hydroperoxy Fatty Acids. These are fatty acids contaning a hydroperoxide group attached to the chain.
N-Dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate
D013501 - Surface-Active Agents > D003902 - Detergents
2-Propanol, 1-((1-methylethyl)amino)-3-(2,4,6-tripropylphenoxy)-
3,7-dimethoxy-2-methyl-5-octanyl-5,6,7,8-tetrahydroquinoline-4(1H)-one|chamaedrone
3-ethyl-2-(2-hydroxy-ethyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-11-ol|Ankorin
C19H29NO4 (335.20964740000005)
(-)-4,4-Diphenyl-6-pyrrolidino-heptan-3-on|(-)-4,4-diphenyl-6-pyrrolidino-heptan-3-one
4-Acetoxy-1,3,5,6-tetramethoxy-2-(N-methylacetylamino)hexane
C15H29NO7 (335.19439239999997)
N3-Ac,N8-Me,10-deoxy-搂脦-(2-Hydroxy-4-oxodecanoyl)histidine
C18H29N3O3 (335.22088040000006)
(1S,Z)-3-((2R,E)-6-hydroxy-2,5-dimethylnon-4-en-1-ylidene)-1-methyloctahydro-2H-quinolizin-1-ol
Norpipanone
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
3-N-BOC-AMINO-1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE
C18H29N3O3 (335.22088040000006)
3-N-BOC-AMINO-1-[2-AMINO-1-(4-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE
C18H29N3O3 (335.22088040000006)
N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Droprenilamine
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-{2-[(trimethylsilyl)oxy]propan-2-yl}pyridine
C17H30BNO3Si (335.20878999999996)
azanium,2-methylidenehexanoic acid,2-methylprop-2-enoate,styrene
C19H29NO4 (335.20964740000005)
Boc-(S)-3-Amino-4-(4-tert-butylphenyl)butyric Acid
C19H29NO4 (335.20964740000005)
azanium,butyl prop-2-enoate,2-methylprop-2-enoate,styrene
C19H29NO4 (335.20964740000005)
D-erythro-Sphingosine hydrochloride
D-erythro-Sphingosine (Erythrosphingosine) hydrochloride is a specific TRPM3 activator. D-erythro-Sphingosine also induces retinoblastoma protein dephosphorylation[1][2].
oxeladin
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
Ontazolast
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
sodium N-methyl-N-(1-oxotetradecyl)-beta-alaninate
C18H34NNaO3 (335.24362540000004)
Boc-(R)-3-AMino-4-(4-tert-butyl-phenyl)-butyric acid
C19H29NO4 (335.20964740000005)
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-8-azabicyclo[3.2.1]oct-3-ene-8-carboxylate
N-tetradecanoyltaurine
C16H33NO4S (335.21301780000005)
A fatty acid-taurine conjugate derived from tetradecanoic acid.
6-(4-benzylpiperidin-1-yl)-N-cyclopropylpyridine-3-carboxamide
2,6,8-Trimethyl-3-amino-9-benzyl-9-methoxynonanoic acid
Myristyltrimethylammonium bromide
D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents
leukotriene B4(1-)
The leukotriene anion that is the conjugate base of leukotriene B4 arising from deprotonation of the carboxylic acid function.
(5S,6E,8Z,11Z,14Z)-5-Hydroperoxyicosa-6,8,11,14-tetraenoate
(5Z,8Z,10E,12S,14Z)-12-Hydroperoxyicosa-5,8,10,14-tetraenoate
15(S)-Hpete(1-)
Conjugate base of 15(S)-HPETE arising from deprotonation of the carboxylic acid function.
(5Z,9E,14Z)-(8XI,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate
Conjugate base of (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.
(5Z,9E,11Z,14Z)-(8S)-8-Hydroperoxyicosa-5,9,11,14-tetraenoate
(5Z,8R,9E,11Z,14Z)-8-hydroperoxyicosa-5,9,11,14-tetraenoate
(5Z,8Z,10E,12R,14Z)-12-hydroperoxyicosa-5,8,10,14-tetraenoate
15(R)-Hpete(1-)
A hydroperoxy fatty acid anion that is the conjugate base of 15(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoate
An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.
(8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoate
An unsaturated fatty acid anion that is the conjugate base of (8R)-hydroxy-(11R,12R)-epoxyicosa-(5Z,9E,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.
(10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoate
An unsaturated fatty acid anion that is the conjugate base of (10R)-hydroxy-(11S,12S)-epoxyicosa-(5Z,8Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.
(13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-Oate
[(4S)-4-cyano-5-methyl-4-phenylhexyl]-methyl-(2-phenylethyl)azanium
7-[(1R,2S)-2-[(E)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]heptanoate
(5Z,8Z,14Z)-(11R,12S)-11,12-Epoxy-10-hydroxyeicosa-5,8,14-trienoate
(5S,7E,9E,11Z,13E,15S)-5,15-dihydroxyicosa-7,9,11,13-tetraenoate
(5Z,11Z,14Z)-(8S,9S,10R)-10-hydroxy-8,9-epoxyicosa-5,11,14-trienoate
(5as,12as,13as)-12,12-Dimethyl-2,3,11,12,12a,13-Hexahydro-1h,5h,6h-5a,13a-(Epiminomethano)indolizino[7,6-B]carbazol-14-One
5-Hpete(1-)
A HPETE anion that is the conjugate base of 5-HPETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
15-Hpete(1-)
A HPETE anion that is the conjugate base of 15-HPETE arising from deprotonation of the carboxylic acid group; major species at pH 7.3.
5(S),15(S)-DiHETE(1-)
An icosanoid anion that is the conjugate base of 5(S),15(S)-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
5(S),11(R)-DiHETE(1-)
An icosanoid anion that is the conjugate base of 5(S),11(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
5(S),15(R)-DiHETE(1-)
An icosanoid anion that is the conjugate base of 5(S),15(R)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
hepoxilin A3(1-)
A hepoxilin anion that is the conjugate base of hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.
hepoxilin B3(1-)
A hepoxilin anion that is the conjugate base of hepoxilin B3, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(8S)-hepoxilin A3(1-)
A hepoxilin A3 anion that is the conjugate base of (8S)-hepoxilin A3, obtained by deprotonation of the carboxylic acid group; major species at pH 7.3.
6-trans-leukotriene B4(1-)
A leukotriene anion that is the conjugate base of 6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
8,20-DiHETE(1-)
An icosanoid anion that is the conjugate base of 8,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
5,20-DiHETE(1-)
An icosanoid anion that is the conjugate base of 5,20-DiHETE, arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
9(R)-Hpete(1-)
A HPETE anion obtained by deprotonation of the carboxy group of 9(R)-HPETE; major species at pH 7.3.
12,20-DiHETE(1-)
An icosanoid anion that is the conjugate base of 12,20-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
11(S)-hydroxy-14(S),15(S)-hepoxilin A3(1-)
An hepoxilin anion that is the conjugate base of 11(S)-hydroxy-14(S),15(S)-hepoxilin A3, arising from deprotonation of the carboxylic acid group; major species at pH 7.3.
(8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoate
An unsaturated fatty acid anion that is the conjugate base of (8S,9S)-epoxy-(10R)-hydroxyicosa-(5Z,11Z,14Z)-trienoic acid, obtained by deprotonation of the carboxy group.
(7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoate
A polyunsaturated fatty acid anion that is the conjugate base of (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoate
An unsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(14S,15S)-epoxyicosa-(5Z,8Z,11Z)-trienoic acid, obtained by deprotonation of the carboxy group.
(5Z,8Z,11R,12E,14Z)-11-hydroperoxyicosa-5,8,12,14-tetraenoate
(5Z,8Z,11Z,13S)-13-hydroxy-13-[(2S,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate
(5S,6E,10E,12E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate
(5Z,8Z,11Z)-13-[3-(5-hydroxypentyl)oxiran-2-yl]trideca-5,8,11-trienoate
(S)-3-{[2-(1,1-dimethylallyl)-indol-3-yl]methyl}-6,7,8,8a-tetrahydropyrrolo[1,2-a]pyrazin-1-one
(5Z,8S,9E,11Z,13E,15S)-8,15-dihydroxyicosa-5,9,11,13-tetraenoate
(5Z,8Z,11Z)-13-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,11-trienoate
(5Z)-7-{3-[(2Z,5Z)-11-hydroxyundeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate
(5Z,8Z)-10-{3-[(2Z)-8-hydroxyoct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate
(5S,6R,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate
(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2S,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2R,3R)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one
C18H29N3O3 (335.22088040000006)
(5Z,8Z,10E,12E,14R,15S)-14,15-dihydroxyicosa-5,8,10,12-tetraenoate
(5Z,8Z,11Z)-13-hydroxy-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate
(5Z,8Z,12E)-11-hydroxy-13-[(2R,3S)-3-pentyloxiran-2-yl]trideca-5,8,12-trienoate
4-{3-[(2Z,5Z,8Z)-14-hydroxytetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate
(5S,6S,7E,9E,11Z,14Z)-5,6-dihydroxyicosa-7,9,11,14-tetraenoate
2-(1,1-Dimethyl-2-propenyl)-3-(1-hydroxy-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-3-ylmethyl)-1H-indole
6-Methoxy-3-methyl-9-[2-(6-methylpyridin-3-yl)ethyl]-1,2,3,4-tetrahydro-gamma-carboline
MTAB
D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AJ - Quaternary ammonium compounds D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AC - Medicated shampoos C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents Same as: D02164
3-[Dodecyl(dimethyl)ammonio]-1-propanesulfonate
D013501 - Surface-Active Agents > D003902 - Detergents
5(S)-HPETE(1-)
Conjugate base of 5(S)-HPETE arising from deprotonation of the carboxylic acid function.
8(R)-HPETE(1-)
Conjugate base of 8(R)-HPETE arising from deprotonation of the carboxylic acid function.
8(S),15(S)-DiHETE(1-)
A DiHETE(1-) that is the conjugate base of 8(S),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
8(S)-HPETE(1-)
A HPETE anion obtained by deprotonation of the carboxy group of (8S)-HPETE.
14(R),15(S)-DiHETE(1-)
A DiHETE(1-) that is the conjugate base of 14(R),15(S)-DiHETE arising from deprotonation of the carboxylic acid function; major species at pH 7.3.
11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoate
An epoxy(hydroxy)icosatrienoate that is the conjugate base of 11 hydroxy-(14R,15S)-epoxy-(5Z,8Z,12E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
12(R)-HPETE(1-)
A hydroperoxy fatty acid anion that is the conjugate base of 12(R)-HPETE, obtained by deprotonation of the carboxy group.
(13S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate
A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13(S)-hydroxy-(14S,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoate(1-)
A 13-hydroxy-14,15-epoxy-(5Z,8Z,11Z)-icosatrienoate that is the conjugate base of 13-hydroxy-(14R,15S)-epoxy-(5Z,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
prostaglandin B1(1-)
A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin B1, obtained by deprotonation of the carboxy group; major species at pH 7.3.
12(S)-HPETE(1-)
Conjugate base of 12(S)-HPETE arising from deprotonation of the carboxylic acid function.
11(R)-HPETE(1-)
A hydroperoxy fatty acid anion that is the conjugate base of 11(R)-HPETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.
AcCa(12:4)
C19H29NO4 (335.20964740000005)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(2s,3s,4as,5s,8ar)-2-methyl-5-[(1z,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate
(1s,13s,15s)-12,12-dimethyl-10,19,21-triazahexacyclo[13.5.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]docosa-3(11),4,6,8,21-pentaen-22-ol
(1r,4r,5s)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-4-hexyl-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C19H29NO4 (335.20964740000005)
3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one
3-hydroxy-3-methyl-2-[(2e)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one
(2s,3s,4as,5r,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate
(1r,12r,13s,18r)-1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one
12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol
(3e)-1-[(2e)-4-hydroxy-5-pentyl-5h-1,3-oxazol-2-ylidene]-4-methylundec-3-en-2-one
(2r,3s)-3-hydroxy-3-methyl-2-[(2e,4s)-4-methylhex-2-en-2-yl]-1-(2-methylpropyl)-5-propanoyl-2h-pyridin-4-one
3-ethyl-2-(2-hydroxyethyl)-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-8-ol
C19H29NO4 (335.20964740000005)
(1s,12r,13r,18s)-12,13,17,17-tetramethyl-3-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹⁶,²⁰]icosa-2(10),4,6,8,16(20)-pentaen-18-ol
1-[(8r)-8-[(1z,4z)-hepta-1,4-dien-1-yl]-6-hydroxy-1,5,9-triazacyclotridec-5-en-1-yl]ethanone
C19H33N3O2 (335.25726380000003)
(2s,3s,4as,5s,8ar)-2-methyl-5-[(1e,3e)-octa-1,3-dien-1-yl]-decahydroquinolin-3-yl 2-hydroxyacetate
(5r,7s)-3,7-dimethoxy-2-methyl-5-octyl-5,6,7,8-tetrahydro-1h-quinolin-4-one
n-{5-[(decyloxy)carbonyl]-2-hydroxyphenyl}ethanimidic acid
C19H29NO4 (335.20964740000005)
1,13,17,17-tetramethyl-2-azapentacyclo[10.8.0.0²,¹⁰.0³,⁸.0¹³,¹⁸]icosa-3,5,7,9-tetraen-16-one
1-[8-(hepta-1,4-dien-1-yl)-6-hydroxy-1,5,9-triazacyclotridec-5-en-1-yl]ethanone
C19H33N3O2 (335.25726380000003)